Is dynamometry able to infer the risk of muscle mass loss in patients with COPD?

dc.contributor.authorRamos, Dionei [UNESP]
dc.contributor.authorBertolini, Giovana Navarro [UNESP]
dc.contributor.authorLeite, Marceli Rocha [UNESP]
dc.contributor.authorSoares Carvalho Junior, Luiz Carlos [UNESP]
dc.contributor.authorSilva Pestana, Paula Roberta da [UNESP]
dc.contributor.authorSantos, Vanessa Ribeiro dos [UNESP]
dc.contributor.authorSouza Fortaleza, Ana Claudia de [UNESP]
dc.contributor.authorMachado Rodrigues, Fernanda Maria [UNESP]
dc.contributor.authorCipulo Ramos, Ercy Mara [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2018-11-26T16:16:14Z
dc.date.available2018-11-26T16:16:14Z
dc.date.issued2015-01-01
dc.description.abstractIntroduction: Sarcopenia is characterized by a progressive and generalized decrease of strength and muscle mass. Muscle mass loss is prevalent in patients with chronic obstructive pulmonary disease (COPD) as a result of both the disease and aging. Some methods have been proposed to assess body composition (and therefore identify muscle mass loss) in this population. Despite the high accuracy of some methods, they require sophisticated and costly equipment. Aim: The purpose of this study was to infer the occurrence of muscle mass loss measured by a sophisticated method (dual energy X-ray absorptiometry [ DEXA]) using a more simple and affordable equipment (dynamometer). Methods: Fifty-seven stable subjects with COPD were evaluated for anthropometric characteristics, lung function, functional exercise capacity, body composition, and peripheral muscle strength. A binary logistic regression model verified whether knee-extension strength (measured by dynamometry) could infer muscle mass loss (from DEXA). Results: Patients with decreased knee-extension strength were 5.93 times more likely to have muscle mass loss, regardless of sex, disease stage, and functional exercise capacity (P=0.045). Conclusion: Knee-extension dynamometry was able to infer muscle mass loss in patients with COPD.en
dc.description.affiliationSao Paulo State Univ, Dept Physiotherapy, Presidente Prudente, Brazil
dc.description.affiliationSao Paulo State Univ, Dept Motr Sci, Rio Claro, Brazil
dc.description.affiliationUnespSao Paulo State Univ, Dept Physiotherapy, Presidente Prudente, Brazil
dc.description.affiliationUnespSao Paulo State Univ, Dept Motr Sci, Rio Claro, Brazil
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.description.sponsorshipPrograma Institucional da Pro-Reitoria de Extensao - PROEX/UNESP
dc.description.sponsorshipFundação para o Desenvolvimento da UNESP (FUNDUNESP)
dc.format.extent1403-1407
dc.identifierhttp://dx.doi.org/10.2147/COPD.S69829
dc.identifier.citationInternational Journal Of Chronic Obstructive Pulmonary Disease. Albany: Dove Medical Press Ltd, v. 10, p. 1403-1407, 2015.
dc.identifier.doi10.2147/COPD.S69829
dc.identifier.issn1178-2005
dc.identifier.urihttp://hdl.handle.net/11449/160671
dc.identifier.wosWOS:000358282000001
dc.language.isoeng
dc.publisherDove Medical Press Ltd
dc.relation.ispartofInternational Journal Of Chronic Obstructive Pulmonary Disease
dc.rights.accessRightsAcesso restrito
dc.sourceWeb of Science
dc.subjectCOPD
dc.subjectsarcopenia
dc.subjectperipheral muscle strength
dc.titleIs dynamometry able to infer the risk of muscle mass loss in patients with COPD?en
dc.typeArtigo
dcterms.rightsHolderDove Medical Press Ltd

Arquivos